Evidence map›Paper›PMID 22821214›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2013

Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.

Heike E Schneider, Michael Steinmetz, Ulrich Krause, Thomas Kriebel, Wolfgang Ruschewski, Thomas Paul

Abstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Neuromodulation Therapy in Heart Failure: Combined Use of Drugs and Devices.The Journal of innovations in cardiac rhythm management · 2020
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings.Clinical research in cardiology : official journal of the German Cardiac Society · 2015
    Review
  18. Article
  19. Review
  20. Epicardial ablation cures electrical storm caused by cardiac involvement in myotonic dystrophia type 2.Clinical research in cardiology : official journal of the German Cardiac Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heike E SchneiderDepartment for Pediatric Cardiology and Intensive Care Medicine, Georg-August-University Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. heike.schneider@med.uni-goettingen.de
Michael Steinmetz
Ulrich Krause
Thomas Kriebel
Wolfgang Ruschewski
Thomas Paul

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft cardiac sympathetic denervation (LCSD) may be a therapeutic adjunct for young patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) and long QT syndrome (LQTS) who are not fully protected by beta-blockade.

objectiveThe objective of this analysis was to report our institutional experience with LSCD in young patients for the management of life-threatening ventricular arrhythmias in CPVT and LQTS.

methodsTen young patients with CPVT and LQTS underwent transaxillary LSCD at our institution. Mean age at surgery was 14.0 (range 3.9-42) years, mean body weight was 45.7 (range 15.5-90) kg. Five patients had the clinical diagnosis of CPVT, three were genotype positive for a mutation in the ryanodine-receptor-2-gene. Four of five LQTS patients were genotype positive. Indications for LCSD were recurrent syncope, symptomatic episodes of ventricular tachycardias and/or internal cardioverter-defibrillator (ICD) discharges, and aborted cardiac arrest despite high doses of beta-blockers.

resultsLCSD was performed via the transaxillary approach. No significant complications were observed. Two patients already had an ICD, 6 patients received an ICD at the same operation or shortly thereafter. Median length of follow-up after LCSD was 2.3 (range 0.6-3.9) years. After LCSD a marked reduction in arrhythmia burden and cardiac events was observed in all patients while medication was continued. None of the patients had any further ICD discharge for sustained VT.

conclusionsAfter LCSD, arrhythmia burden could significantly be reduced in all our young patients with CPVT and LQTS.

Indexed as

SympathectomyAdolescentAdrenergic beta-AntagonistsAdultAge FactorsAnti-Arrhythmia AgentsChildChild, PreschoolCombined Modality TherapyDeath, Sudden, CardiacDefibrillators, ImplantableElectric CountershockElectrocardiographyFemaleGenetic Predisposition to DiseaseHeartAdrenergic beta-AntagonistsAnti-Arrhythmia AgentsRyanodine Receptor Calcium Release Channel

Identifiers

PMID22821214
PMCPMC3536998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.